Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Neurology

SREAT Relapse vs. Steroid Withdrawal: Warning Signs

At a Glance

During a steroid taper, SREAT relapse may cause renewed confusion, severe memory or speech problems, balance changes, involuntary movements, or major mood and behavior changes, but withdrawal and adrenal insufficiency can look similar. A clinician must assess new symptoms.

Tapering off corticosteroids after being treated for Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT, also known as Hashimoto’s encephalopathy) can be a highly anxious time. Relapses have been reported during dose reductions and after stopping medications, though their exact frequency and timing are uncertain [1][2].

Because tapering steroids also causes a predictable withdrawal process, it can be very difficult to know if your body is just adjusting to lower medication levels, if your adrenal glands are struggling, or if SREAT is returning. It is crucial to understand that you cannot reliably diagnose the cause of your symptoms at home. While withdrawal often causes physical fatigue and SREAT often causes neurological issues, these conditions overlap significantly. For example, a relapse might begin with generalized fatigue, while withdrawal or adrenal insufficiency can cause confusion, sleep disturbances, and mood changes [3][4][5]. Always seek a clinician’s assessment for new or worsening symptoms rather than trying to diagnose yourself based on how a symptom feels.

🚨 EMERGENCY RED FLAGS

Do not wait for a doctor’s appointment, a scheduled test, or a callback if you experience any of the following. Call emergency services immediately. These can be signs of a life-threatening adrenal crisis, a severe SREAT relapse, an infection, or another medical emergency like a stroke:

  • Neurological emergencies: First or prolonged seizures, sudden inability to speak or walk, markedly reduced consciousness, coma, or rapidly worsening confusion [3][6].
  • Psychiatric emergencies: New severe psychosis, delusions, or hallucinations [3].
  • Adrenal Crisis signs: Collapse, fainting (syncope), severe dizziness upon standing (hypotension), persistent vomiting, inability to keep steroid medication down, or severe physical weakness [7][5].

Potential Signs of a SREAT Relapse

A SREAT relapse means the encephalopathy (brain dysfunction) has returned. During a steroid reduction, relapses often—but not always—mimic the exact symptoms you experienced during your initial episode [2][1]. Features that raise clinical concern for a relapse include:

  • Cognitive and Neurological Deficits: Severe memory impairment, confusion, clumsiness or loss of balance (gait disturbance), speech problems, and involuntary movements [3][2].
  • Psychiatric Changes: Profound mood swings, major behavioral changes, or persecutory delusions (beliefs that someone is trying to harm you) [3]. (Note: Corticosteroids themselves, as well as adrenal issues, can also cause significant psychiatric side effects, meaning any severe mood or behavioral change requires formal medical evaluation).

Glucocorticoid Withdrawal and Adrenal Insufficiency

When you take high doses of steroids for a prolonged period, your body’s adrenal glands suppress their natural production of cortisol. As you taper, it takes time for this system to recover [8].

  • Glucocorticoid Withdrawal Syndrome: This common adjustment period often causes profound generalized fatigue, muscle aches (myalgias), joint pains (arthralgias), sleep disturbances, and mild to moderate mood changes [4][9].
  • Adrenal Insufficiency: If your adrenal glands do not wake up adequately, you may develop adrenal insufficiency. This can happen gradually, causing increasing fatigue, nausea, and weakness. If severe, it can culminate in a sudden, life-threatening adrenal crisis [7][5].

Why Diagnosis Requires Your Doctor

There is no single confirmatory test for a SREAT relapse, and your care team will need to evaluate you to rule out other causes like infections, medication side effects, or metabolic imbalances [10].

  • Scans and tests can be normal: Having a normal brain MRI or normal routine cerebrospinal fluid (CSF) results does not exclude a relapse [2]. An EEG (brain wave test) is often abnormal in SREAT (typically showing generalized slowing), but this finding is nonspecific and cannot definitively prove a relapse on its own [3].
  • Antibodies are not proof of relapse: High thyroid antibodies are common in autoimmune thyroid disease but do not measure current brain inflammation. In one study of patients referred for suspected Hashimoto’s encephalopathy who had elevated thyroid antibodies, 73% were ultimately found to have a completely different, non-immune diagnosis [11].
  • Adrenal testing: Your doctor may use tests like a morning cortisol draw or an ACTH stimulation test to check if your adrenal glands are recovering [12].

Your Action Plan

  • Follow your taper strictly: Do not speed up, stop, or change your long-term steroid taper without your prescriber’s direction.
  • Use sick-day rules if prescribed: If your doctor has given you a specific “sick-day plan” (instructions to take extra steroids during a fever, major illness, or vomiting) or an emergency hydrocortisone injection kit, follow those instructions and seek immediate medical care.
  • Track your symptoms: Keep a daily symptom diary noting your current dose, the timing of symptoms relative to dose reductions, sleep patterns, and any physical or neurological changes. This gives your care team objective data to review.

Common questions in this guide

What are possible signs of a SREAT relapse during a steroid taper?
A possible relapse may cause severe memory problems, confusion, trouble speaking, clumsiness or loss of balance, involuntary movements, or major changes in mood or behavior. Delusions, hallucinations, seizures, or reduced alertness are more serious warning signs. These symptoms can overlap with steroid withdrawal and other illnesses, so a clinician needs to assess them.
How can I tell a SREAT relapse from steroid withdrawal?
You cannot reliably tell the difference at home. Withdrawal more often causes generalized fatigue, muscle or joint aches, sleep problems, and mild-to-moderate mood changes, while relapse may involve pronounced cognitive, neurological, or psychiatric changes; however, the patterns overlap. New or worsening symptoms should be discussed with your care team.
When should I call emergency services during a steroid taper?
Call emergency services for a first or prolonged seizure, sudden inability to speak or walk, markedly reduced consciousness, rapidly worsening confusion, severe psychosis, collapse or fainting, severe dizziness when standing, persistent vomiting, inability to keep steroid medicine down, or severe weakness. These symptoms may indicate adrenal crisis, a severe relapse, infection, stroke, or another emergency. Do not wait for routine testing or a callback.
Can a normal MRI or high thyroid antibodies rule out a SREAT relapse?
No. A normal brain MRI or routine spinal-fluid test does not exclude relapse, and an EEG can be abnormal without proving that a relapse is occurring. High thyroid antibody levels also do not show whether brain inflammation is active, so clinicians must consider other causes and the full clinical picture.
What tests might show whether my symptoms are from adrenal suppression?
A clinician may order a morning cortisol blood test or an ACTH stimulation test, which checks the adrenal glands' response, to assess recovery. They may also evaluate for infection, medication effects, or metabolic problems because no single test confirms a SREAT relapse. Results must be interpreted alongside symptoms and medical history.
Should I change my steroid dose if symptoms return during the taper?
Do not speed up, stop, or change a long-term steroid taper without speaking with the prescribing clinician. Follow any written sick-day instructions or emergency hydrocortisone plan you were given, especially during fever, serious illness, vomiting, or inability to keep medicine down. Seek immediate care for emergency symptoms.

Get notified when new evidence is published on Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    A young man with convulsive laughter.

    Toft A, Meisingset TW, Sæther SG

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020; (140(8)) doi:10.4045/tidsskr.19.0612.

    PMID: 32463185
  2. 2

    [A suspected case of Hashimoto encephalopathy with frequent relapses despite multiple courses of immunotherapy].

    Harada S, Inatomi Y, Nakajima M, Yonehara T

    Rinsho shinkeigaku = Clinical neurology 2020; (60(3)):200-205 doi:10.5692/clinicalneurol.cn-001361.

    PMID: 32101843
  3. 3

    Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.

    Laurent C, Capron J, Quillerou B, et al.

    Autoimmunity reviews 2016; (15(12)):1129-1133 doi:10.1016/j.autrev.2016.09.008.

    PMID: 27639840
  4. 4

    Potential mechanisms of the glucocorticoid withdrawal syndrome.

    Snyder CN, Frontera ED, Meng J, et al.

    European journal of endocrinology 2026; (194(4)):R67-R81 doi:10.1093/ejendo/lvag062.

    PMID: 41988948
  5. 5

    Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency.

    Borresen SW, Klose M, Glintborg D, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(7)):2065-2076 doi:10.1210/clinem/dgac151.

    PMID: 35302603
  6. 6

    Super refractory status epilepticus as an atypical presentation of Hashimoto's encephalopathy.

    Chaponan-Lavalle A, Alave J, Fernandez F, et al.

    Epilepsy & behavior reports 2026; (34()):100862 doi:10.1016/j.ebr.2026.100862.

    PMID: 41908686
  7. 7

    Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis.

    Laugesen K, Petersen I, Sørensen HT, Jørgensen JOL

    PloS one 2019; (14(2)):e0212259 doi:10.1371/journal.pone.0212259.

    PMID: 30779776
  8. 8

    European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.

    Beuschlein F, Else T, Bancos I, et al.

    European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.

    PMID: 38714321
  9. 9

    Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.

    Zhang CD, Li D, Singh S, et al.

    European journal of endocrinology 2023; (188(7)):592-602 doi:10.1093/ejendo/lvad073.

    PMID: 37395115
  10. 10

    Hashimoto's Encephalopathy: Case Series and Literature Review.

    Chaudhuri J, Mukherjee A, Chakravarty A

    Current neurology and neuroscience reports 2023; (23(4)):167-175 doi:10.1007/s11910-023-01255-5.

    PMID: 36853554
  11. 11

    Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.

    Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al.

    Brain communications 2021; (3(2)):fcaa233 doi:10.1093/braincomms/fcaa233.

    PMID: 34061124
  12. 12

    Morning serum cortisol as a predictor of synacthen stimulation test outcomes during corticosteroid withdrawal: a comparative analysis of high-dose and low-dose protocols.

    Saiegh L, Dakwar B, Jovanovic K, et al.

    Frontiers in endocrinology 2025; (16()):1655146 doi:10.3389/fendo.2025.1655146.

    PMID: 41122714

This page is for informational purposes only and does not constitute medical advice or diagnose SREAT relapse, steroid withdrawal, or adrenal insufficiency. Follow your prescriber's taper plan and seek emergency care for severe neurological symptoms, collapse, persistent vomiting, or inability to keep steroids down.